Liver Regeneration Using Cell Therapy May be Possible, Study Suggests
Liver transplantation is the mainstay of treatment for patients with end-stage liver disease, the twelfth leading cause of death in the United States, but new research from the Icahn School of Medicine at Mount Sinai, published in the online journal Cell Stem Cell, suggests that it may one day become possible to regenerate a liver using cell therapy in patients with liver disease. "The discovery of the novel progenitor represents a fundamental advance in this field and potentially to the liver regeneration field using cell therapy," said the study's senior author, Valerie Gouon-Evans, PharmD, PhD, Assistant Professor, in the Department of Developmental and Regenerative Biology, Black Family Stem Cell Institute, at the Icahn School of Medicine at Mount Sinai.
-Dr. Valerie Gouon-Evans, Assistant Professor, Developmental and Regenerative Biology, Medicine, Liver Diseases, Icahn School of Medicine at Mount Sinai
Learn more
Mount Sinai Launches Discovery and Innovation Center in Midtown West
Oct 05, 2023 View All Press Releases